AMSTERDAM, February 16, 2011 - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the year to December 31, 2010.

Enhances Enterprise Systems for Highly Virtualized and Private Cloud Deployments Redwood Shores, Calif. – February 15, 2011

Introduces First set of Pre-Built Integrations Certified for Oracle Fusion Middleware 11g Redwood Shores, CA – February 15, 2011

Network Optimization Solution Reduces Capital Expenses and Streamlines Ongoing Operational Costs

MOBILE WORLD CONGRESS, BARCELONA, Spain – Feb. 15, 2011News Facts